9-12 months short treatment for patients with MDR-TB increases treatment success in Kyrgyzstan

9-12 months short treatment for patients with MDR-TB increases treatment success in Kyrgyzstan

Introduction: MDR/RR-TB is a growing problem in Kyrgyzstan. In 2005, the country introduced standard or individualized treatment for 20-24 months. Because of poor treatment outcomes, in 2017 a short treatment with strict eligibility criteria was introduced. The aim of this study was to compare char...

Full description

Saved in:
Bibliographic Details
Main Authors: Elena Zhdanova, Olga Goncharova, Hayk Davtyan, Sevak Alaverdyan, Aelita Sargsyan, Anthony D Harries, Bolot Maykanaev
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2021-09-01
Series:Journal of Infection in Developing Countries
Subjects:
SORT IT
MDR/RR-TB
treatment outcomes
sputum culture conversion
short treatment
standard or individualized treatment
Online Access:https://jidc.org/index.php/journal/article/view/13757
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/13757

Similar Items